In silico analysis of the pharmacokinetic and toxicological profile of drugs in research for the treatment of COVID-19
DOI:
https://doi.org/10.33448/rsd-v9i11.9450Keywords:
COVID-19; Analysis in silico; Chloroquine.Abstract
The objective of the research is to provide information on the drugs under study for the treatment of Covid-19, as well as to elucidate data on pharmacokinetic and toxicological parameters that may impact the therapy of patients affected by coronavirus, by an in silico analysis. To achieve the proposed objectives, in silico tools were used, using ACD/Chem Sketch (version 14.0) and Marvin Sketch software. The analysis of pharmacokinetic and toxicological parameters was performed through the Preadmet server, which predicts the data based on the structure/activity relationship. To complement the data collected in computational tools, a bibliographic survey was performed in the main databases on the analyzed parameters. According to the analysis of the ADME results, abiraterone and brequinar medications present the most desirable pharmacokinetic parameters. Some of the drugs observed demonstrated satisfactory responses, especially chloroquine, which met the passage parameter in the HBS, since the coronavirus has been causing manifestations in the CNS, however, this medication is related to the growth of arrhythmia deaths. On the other hand, the toxicological parameters present mostly non-mutagenic and non-ccarcinogenic drugs and, in relation to hERG, most of them are classified as medium risk. The drugs used to treat cardiopathic patients should be chosen carefully, as some of them increase cardiac risk. Ivermectin and nitazoxanide present metabolites with mutagenic potential, therefore they should be used with caution.
References
Alliance, d (2016). Estudo químico, predições in silico das propriedades adme/tox e atividade larvicida do óleo essencial da raiz philodendron deflexum poepp. Ex schott sobre aedes egypti linneu e anopheles albirtasis s.l. Recuperado de: https://www2.unifap.br/ppcs/files/2017/12/estudo-qu%c3%8dmico-predi%c3%87%c3%95es-in-silico-das-propriedades-admetox-e-atividade-larvicida-do-%c3%93leo-essencial-da-raiz-philodendron-deflexum-poepp.-ex-schott-sobre-aedes.pdf
Amin, L (2013). P-glycoprotein inhibition for optimal drug delivery. Drug Targets Insights, 7, 27-34.
Ando, H., Hisaka, A., & Suzuki, H. (2015). A new physiologically based fármacokinetic model for the prediction of gastrointestinal drug absorption: translocation model. Drug Metabolism and Disposition, 23(4), 590-602.
Benfenati, E. (Ed.). (2016). In silico methods for predict in gdrug toxicity. Humana Press.
Brasil (2020). Covid-19 no Brasil. Recuperado de: https://susanalitico.saude.gov.br/extensions/covid-19_html/covid-19_html.html
Brasil. (2013). Guia para a condução de estudos não clínicos de toxicologia e segurança farmacológica necessários ao desenvolvimento de medicamentos (versão 2). Brasília: Agência Nacional de Vigilância Sanitária.
Calixto, L. A. (2012). Métodos de análise da rosiglitazona e pioglitazona e de seus principais metabólitos: aplicações de estudo de metabolismoin vitro. 148f. Tese de doutorado. Faculdade de Ciências Farmacêuticas de Ribeirão Preto – Universidade de São Paulo. Ribeirão Preto, Brasil.
Dolabela, M. F., Silva, A. R. P. D., Ohashi, L. H., Bastos, M. L. C., Silva, M. C. M. D. & Vale, V. V. (2018). Estudo in silico das atividades de triterpenos e iridoides isolados de Himatanthus articulatus (Vahl) Woodson. Revista Fitos, 12(3), 227-242.
Efinger, A., O'Driscoll, C. M., McAllister, M. & Fotaki, N. (2018). Previsão ADME In vitro e In silico. Em A. Talevi, e PA Quiroga (Eds.), Processos ADME em Ciências Farmacêuticas: Dosagem, Design e Farmacoterapia Sucesso Springer.
Felice, F. G. De., Moll, F. T., Moll, J., Munoz, D. P. & Ferreira, S T. (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends in Neurosciences.
Franco, G. C. N., Cogo, K., Montan, M. F., Bergamaschi, C. de C., Groppo, F. C., Volpato, M. C., Andrade, E. D. de & Rosalen, P. L. (2007) Interações medicamentosas: fatores relacionados ao paciente (Parte I). Rev. Cir. Traumatol. Buco-Maxilo-fac., Camaragibe.
Golan, D. E., Jr Tashjian, A., Armstrong, E, J & Armstrong, A, W. (2017). Princípios de Farmacologia: a base fisiopatológica da farmacologia. Rio de Janeiro: Guanabara Koogan.
Grandis, R. A. (2016). Avaliação da atividade mutagênica de complexos heterolépticos de Rutênio (II) com atividade anti - Mycobacterium tuberculosis. p. 36-37. Dissertação – Faculdade de Ciências Farmacêuticas – USP. Araraquara, São Paulo.
Guan, W., Ni, Yu Hu, Z., Liang, C. W., Ou, J. H., Liu, H. L., Shan, C. L., Hui, D.S.C., Du, B., Li, L., Zeng, G Yuen., K. Y., Chen, R., Tang, C., Wang, T., Chen, P., Xiang, J., Li S., Wang, J., Liang, Z., Peng, Y., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S., Zhong N., (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382, 1708-1720.
Jing, Y., Easter, A., Peters, D., Kim, N., & Enyedy, I. J. (2015). In silico prediction of hERG inhibition. Future medicinal chemistry, 7(5), 571-586.
Jónsdóttir, S. Ó., Jørgensen, F. S., & Brunak, S. (2005). Prediction methods and databases with in chemo informatics: emphasis on drugs and drug candidates. Bioinformatics, 21(10), 2145-2160.
Kauffmann, K., Gremm, L., Brendt, J., Schiwy, A., Bluhm, K., Hollert, H. & Büchs, J. (2020). Alternative typeof Ames testallows for dynamics mutagenicity detection by online monitoring of respiration activity. Science of The Total Environment, 137862.
Le, J. Absorção de medicamentos (2019). Recuperado de: https://www.msdmanuals.com/pt/casa/medicamentos/administra%C3%A7%C3%A3o-de-medicamentos-e-farmacocin%C3%A9tica/absor%C3%A7%C3%A3o-de-medicamentos.
Mehra, R. M., Dersai, S. S., Ruschitzka, F. & Patel, A.N. (2020). Hydroxychloroquine or chloroquine with or with out a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet, (20), 31180-6.
Moda, T. L (2011). Modelagem in silico de propriedades farmacocinéticas para avaliação de candidatos a novos fármacos (Doctoral dissertation, Universidade de São Pualo).
Moreira, R. R. D., Santos, L.E., Varella, S.D., Varanda, E. A. & Vilegas, W. (2002). Avaliação da atividade mutagênica do extrato etanólico bruto de Paepalanthus laipes (Eriocaulaceae) e dos compostos flavonoidicos 7- metoxilados relacionados. Revista Brasileira de Farmacognosia, 12 (1), 11-19.
Pimentel, V. D., Gomes, G. F., Costa, C. L. S. da. & Alves, W. dos S. Avaliação do potencial toxicológico e farmacocinético in sílico de Anadantoflavona. Princípios em farmácia, 3, 20-25.
Ohta, Y., Kazuki, K., Abe, S., Oshimura, M., Kobayashi, K. & Kazuki, Y. (2020). Developmentof Caco-2 cellsexpressing four CYPs via a mammalian artificial chromosome. BMC Biotechnology, 20 (44), 1-10.
Oliveira, E. H. A. (2020). Coronavírus: Prospecção cientifica e tecnológica dos fármacos em estudo para tratamento da Covid-19. Cadernos de Prospecção, 13, (2), 412-423.
Organização Mundial de Saúde. (2020). Pandemia por doença de coronavírus. Recuperado de: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Rodrigues, N. F., Sacramento, C Q., Lima8, C. R., Silva, F. S. da,. Ferreira1, A, C., Mattos, M., de Freitas, C. S. de, Soares, V. C., Dias, S. da S. G., Temerozo, J. R., Miranda, M., Matos, A. R., Bozza, F. A., Carels, N., Alves, C. R., Siqueira, M. M., Bozza,P. T., Souza, T. M. L., (2020). Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production. Cold Spring Harbor Laboratory, (1), 020925.
Rothan, H. A., Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433.
Santos, R. da C., Daniel, I. C., Próspero, D. F. A., & Costa, L. S. (2018). Modificação molecular incremental: análise de parâmetros físicoquímicos, farmacocinéticos e toxicológicos in silico de fármacos inibidores seletivos da recaptação de serotonina (ISRSs). Boletim Informativo Geum, 9 (2), 31-38.
Sharma, G., Lakkadwala, S., Modgil, A. & Singh, J. (2016). The role ofcell-penetratingpeptideandtransferrinonenhanceddeliveryofdrugtobrain. International Journalof molecular sciences,17 (6), 806-821.
Wolrd Health Organization. (2020). Q&A: Hydroxychloroquine and COVID-19. Recuperado de: https://www.who.int/news-room/q-a-detail/q-a-hydroxychloroquine-and-covid-19.
Zeiger, E.(2019). The test thatchangedthe world: the Ames test and the regulation of chemicals. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 841, 43–48.
Zhu, L., Zhao, J., Zhang, Y., Zhou, W., Yin, L., Wang, Y., Fan, Y., & Liu, H. (2018). ADME properties evaluation in drug discovery: In silico prediction of blood brain partitioning. Molecular diversity, 22(4), 979-990.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Kallyne Zilmar Cunha Bastos; Andreza Huete da Silva Cortêz; Thalya Huet Carneiro Cortêz; Ingrid Sousa Pinto ; Joubert Aires de Sousa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
